The 2021 Medtech Contract Manufacturing Report

Download
innovation hub

Delcath Systems (NASDAQ: DCTH) is Profiled in this Database

Updated At 02 Oct, 2016

Start Free 7 Day Trial Now
Partial description of this company
High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Delcath Systems (NASDAQ: DCTH) plus 4845 other startups.

Start Free 7 Day Trial Now

Learn More About Delcath Systems (NASDAQ: DCTH)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png